EORTC protocol 55875

Intraperitoneal Cisplatin versus no further treatment: A phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based induction chemotherapy and cytoreductive surgery
Trial StatusAll trial activities ended
DatesDate of activation: 15-Feb-88
Closed on : 14-Apr-97
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size312
Number of steps1
Drug
Study StaffMartine Piccart (Study Coordinator) - Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet, Brussels
Type of cancerOvarian
Participating GroupsEORTC Gynecological Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section